Literature DB >> 11756914

Mechanism of pancreatitis caused by ERCP.

Ryukichi Akashi1, Takeaki Kiyozumi, Tomofumi Tanaka, Kouichi Sakurai, Yasushi Oda, Katsuro Sagara.   

Abstract

BACKGROUND: Acute pancreatitis can develop after either ERCP or endoscopic sphincterotomy (ES). The pathogenesis of this complication remains poorly understood.
METHODS: The frequency and severity of acute pancreatitis were retrospectively evaluated after 17,602 ERCP procedures and 3003 ES procedures. Pancreatitis was diagnosed and evaluated according to the scoring system of Ranson and criteria developed in Japan.
RESULTS: Pancreatitis developed after 15 (0.09%) of 17,602 ERCP procedures and 13 (0.43%) of 3003 ES procedures (p = 0.0001, chi-square). The severity of pancreatitis (Ranson score) was less than 3 in 10 cases of ERCP-induced pancreatitis and from 3 to 5 in 5 cases. One (7%) of the 15 patients with ERCP-related pancreatitis died. All 13 patients with ES-induced pancreatitis had a Ranson score of less than 3; none died (p = 0.04, Fisher exact test). The ERCP pancreatitis score (Japanese criteria) beyond 48 hours after the onset of pancreatitis increased in 5 (33%) of the 15 patients with ERCP-induced pancreatitis; the score did not increase in any of the 13 patients with ES-induced pancreatitis (p = 0.04, Fisher exact test).
CONCLUSIONS: Although the frequency of ES-induced pancreatitis is significantly higher than that of post-ERCP pancreatitis, the frequency of severe pancreatitis within 48 hours and worsening of pancreatitis after 48 hours is significantly lower with ES-induced pancreatitis. Our hypothesis is that the lowering of pancreatic intraductal pressure after ES mitigates the severity of postprocedure pancreatitis.

Entities:  

Mesh:

Year:  2002        PMID: 11756914     DOI: 10.1067/mge.2002.118964

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  17 in total

Review 1.  Endoscopic papillotomy, syn. sphincterotomy: results from the past two years.

Authors:  Meinhard Classen; Peter Born
Journal:  Curr Gastroenterol Rep       Date:  2004-04

Review 2.  Endoscopic papillary large balloon dilation for the removal of bile duct stones.

Authors:  Jin Hong Kim; Min Jae Yang; Jae Chul Hwang; Byung Moo Yoo
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

3.  Prophylactic pancreatic stents: does size matter? A comparison of 4-Fr and 5-Fr stents in reference to post-ERCP pancreatitis and migration rate.

Authors:  Albert Pahk; Johanne Rigaux; Vijay Poreddy; Joan Smith; Firas Al-Kawas
Journal:  Dig Dis Sci       Date:  2011-04-13       Impact factor: 3.199

4.  Acute Pancreatitis After Percutaneous Biliary Drainage: An Obstacle in Liver Surgery for Proximal Biliary Cancer.

Authors:  Nadia Russolillo; Andrea Massobrio; Serena Langella; Roberto Lo Tesoriere; Paolo Carbonatto; Alessandro Ferrero
Journal:  World J Surg       Date:  2017-06       Impact factor: 3.352

Review 5.  Balloon dilation itself may not be a major determinant of post-endoscopic retrograde cholangiopancreatography pancreatitis.

Authors:  Sung Ill Jang; Gak Won Yun; Dong Ki Lee
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

6.  Endoscopic papillary large balloon dilation for treatment of large bile duct stones does not increase the risk of post-procedure pancreatitis.

Authors:  Jun Suk Park; Tae Nyeun Kim; Kook Hyun Kim
Journal:  Dig Dis Sci       Date:  2014-07-05       Impact factor: 3.199

7.  Pilot study of aprepitant for prevention of post-ERCP pancreatitis in high risk patients: a phase II randomized, double-blind placebo controlled trial.

Authors:  Tilak Upendra Shah; Rodger Liddle; M Stanley Branch; Paul Jowell; Jorge Obando; Martin Poleski
Journal:  JOP       Date:  2012-09-10

8.  Acute pancreatitis: an under-recognized risk of percutaneous transhepatic distal biliary intervention.

Authors:  A Z Al-Bahrani; A Holt; A M Hamade; G H Abid; H-U Laasch; S J O'Shea; S H Lee; B J Ammori
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

Review 9.  Pancreatitis after endoscopic retrograde cholangio-pancreatography.

Authors:  Ayman M Abdel Aziz; Glen A Lehman
Journal:  World J Gastroenterol       Date:  2007-05-21       Impact factor: 5.742

Review 10.  Pharmacological prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis.

Authors:  Hemant Pande; Paul Thuluvath
Journal:  Drugs       Date:  2003       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.